Navigation Links
Amylin Co-Founder Announces Plans to Vote for Eastbourne Slate
Date:5/11/2009

FRANKFORT, Mich., May 11 /PRNewswire/ -- The following is being released today by Howard E. Greene, Jr.

To my fellow shareholders:

As the founding CEO of Amylin and a board member for almost 22 years, I want you to know how I plan to vote at our annual meeting.

In my opinion Amylin's talented employee team has created one of the best product and technology platforms in the diabetes and obesity area. But, shareholders have suffered because sales results have not reflected the commercial potential of that platform.

I commend our present management team, under Dan Bradbury's leadership, for recognizing that they need to achieve a more effective working relationship with Lilly, and that they must design a more innovative strategy for convincing primary care physicians that Amylin's injectible medicines are their best treatment option for patients with diabetes.

Our board of directors will play a strategic role in meeting these challenges. I believe management will have more freedom to think outside of the box if we replace the directors most directly involved in crafting the disappointing commercialization strategy.

Also, with the departures of Ginger Graham and me, the Amylin board loses more than 60% of its stock ownership. I think our investors would be well served by adding directors who directly represent large shareholdings.

So, I have decided to vote for the slate proposed by Eastbourne, including the Icahn nominees.

Respectfully,

Howard E. Greene, Jr., Co-Founder of Amylin


'/>"/>
SOURCE Howard E. Greene, Jr.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  Prima Biomed Ltd. ... that is striving to become a leader in the ... recently announced that the final CVac data from the ... a clear trend for a clinically meaningful improvement in ... second remission patients. In the group of ...
(Date:5/21/2015)... Imagine being able to probe and truly ... Being able to read faces and enjoy genuine invisible ... their thoughts and actions like never before. Use ... unique abstract paintings and video, or, play a completely ... as it creates action, dialog, and outcomes based on ...
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: ... on the development of autologous cell therapies, announced ... Society for Cellular Therapy (ISCT) on RepliCel,s autologous ... a Phase 1/2 clinical trial.  The presentation, taking ... PM to 7:00 PM local time, will review ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3
... Renowned Clinical Authorities to Advise on Development of New Drug ... Candidate to Treat Autoimmune Disease ... a privately-held drug development company, announced today that it,has appointed ... a peptide fusion protein licensed from Amgen in December 2007 ...
... Merchandisers to Sell Unique Back and Other Pain ... ... Sheets: BIEL), announced today that it has signed a,sales, marketing and distribution ... leading Canadian sales and marketing,distributor of natural health products, medical devices, and ...
... BRISBANE, Australia, Feb. 5 Xenome Limited today,announced ... Company,s Chief,Executive Officer. Dr. Nisbet will also join ... previously worked in senior management and executive,roles in ... Meditech Research Ltd, Millennium Pharmaceuticals Inc,and CSL Ltd. ...
Cached Biology Technology:Anthera Pharmaceuticals Forms Scientific Advisory Board 2BioElectronics Announces Canadian Retail Product Launch 2Xenome Names Ian T. Nisbet, PhD as Chief Executive Officer 2
(Date:5/19/2015)... Fingerprint Cards (FPC) has received an order for ... from one if its module partners. Deliveries are planned to ... the sensors will be used by smartphone manufacturers in ... amount to 740 MSEK to date. In addition to previously ... number of smaller orders not separately communicated amounting to more ...
(Date:5/14/2015)... 2015  Verificient Technologies, Inc., a technology ... remote proctoring, announced a new alliance partnership ... creator of the Canvas Learning Management System ... will benefit from the seamless integration of ... a fully integrated multifactor biometrics behavioral application, ...
(Date:5/8/2015)... , May 8, 2015 Synaptics Inc. (NASDAQ: ... announced that members of the executive management team will present ... Annual Technology, Media and Telecom Conference Date: May 18, ... Boston, MA Cowen and ... Time: 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Synaptics to Present at Upcoming Investor Conferences 2
... researchers led by Richard Van Emmerik at the University ... through the Navy Health Research Center in the Department ... load carried by soldiers, which can be even heavier ... and ability to carry out missions. "Load is ...
... This press release is available in German . ... tunicate maize, the maize kernels on the cob are not ,naked, ... scientists from the Max Planck Institute for Plant Breeding Research in ... the activity of a leaf gene in the maize cob that ...
... /PRNewswire-iReach/  -- Global Information Inc. is announces limited time ... important Boston healthcare conferences: Next-Gen Kinase ... rapidly maturing kinase inhibitors field will gather to explore ... Next-Gen Kinase Inhibitors Conference in Cambridge, MA. ...
Cached Biology News:Kinesiology team gets $975,000 Defense grant to study effects of heavy loads on soldiers 2Pod corn develops leaves in the inflorescences 2Pod corn develops leaves in the inflorescences 3Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27 2Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27 3
... flask clips, purpose-designed to firmly retain glassware, ... are equipped with a top retainer spring; ... bottom retainer spring, and silicon tubing spring ... Clips include the required mounting screws., ...
... shaker flask clips, purpose-designed to firmly retain ... clips are equipped with a top retainer ... a bottom retainer spring, and silicon tubing ... glassware. Clips include the required mounting ...
Anti-Tissue Trans-glutaminase (IgA) EIA Sample Size: 10 l...
... Heavy duty stainless-steel shaker flask clips, purpose-designed ... speeds. All clips are equipped with ... 1L.) also include a bottom retainer spring, ... scratching of expensive glassware. Clips include ...
Biology Products: